Heparan sulfate proteoglycan 2 polymorphism in Alzheimer's disease and correlation with neuropathology

Neuroscience Letters

Volumn 352, Issue 2, 2003, Pages 146-150

  Iivonen, Susan ^a,b   Helisalmi, Seppo ^a,b   Mannermaa, Arto ^a   Alafuzoff, Irina ^a   Lehtovirta, Maarit ^a,c   Soininen, Hilkka ^a,b   Hiltunen, Mikko ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c JORVI HOSPITAL   (Finland)

Author keywords

Alzheimer's disease; Apolipoprotein E; Association; Glycosaminoglycan; Heparan sulfate proteoglycan 2; Paired helical filament tau

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; PROTEOHEPARAN SULFATE; TAU PROTEIN;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FINLAND; GENETIC ASSOCIATION; GENETIC RISK; HETEROZYGOTE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; NUCLEOTIDE SEQUENCE; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0242475049     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.08.041     Document Type: Article

References (21)

1. Alafuzoff I., Helisalmi S., Mannermaa A., Riekkinen P. Sr., Soininen H. beta-Amyloid load is not influenced by the severity of cardiovascular disease in aged and demented patients. Stroke. 30:1999;613-618.
2. Bonay P., Avila J. Apolipoprotein E4 stimulates sulfation of glycosaminoglycans in neural cells. Biochim. Biophys. Acta. 1535:2001;217-220.
3. Cai H., Wang X.L., Wilcken D.E. Genetic polymorphism of heparan sulfate proteoglycan (perlecan, HSPG2), lipid profiles and coronary artery disease in the Australian population. Atherosclerosis. 148:2000;125-129.
4. Cardin A.D., Hirose N., Blankenship D.T., Jackson R.L., Harmony J.A., Sparrow D.A., Sparrow J.T. Binding of a high reactive heparin to human apolipoprotein E: identification of two heparin-binding domains. Biochem. Biophys. Res. Commun. 134:1986;783-789.
5. Castillo G.M., Lukito W., Wight T.N., Snow A.D. The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation. J. Neurochem. 72:1999;1681-1687.
6. Castillo G.M., Ngo C., Cummings J., Wight T.N., Snow A.D. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability. J. Neurochem. 69:1997;2452-2465.
7. Goedert M., Jakes R., Spillantini M.G., Hasegawa M., Smith M.J., Crowther R.A. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature. 383:1996;550-553.
8. Hansen P.M., Chowdhury T., Deckert T., Hellgren A., Bain S.C., Pociot F. Genetic variation of the heparan sulfate proteoglycan gene (perlecan gene). Association with urinary albumin excretion in IDDM patients. Diabetes. 46:1997;1658-1659.
9. Hasegawa M., Crowther R.A., Jakes R., Goedert M. Alzheimer-like changes in microtubule-associated protein Tau induced by sulfated glycosaminoglycans. Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation. J. Biol. Chem. 272:1997;33118-33124.
10. Hiltunen M., Mannermaa A., Koivisto A.M., Lehtovirta M., Helisalmi S., Ryynanen M., Riekkinen P. Sr., Soininen H. Linkage disequilibrium in the 13q12 region in Finnish late onset Alzheimer's disease patients. Eur. J. Hum. Genet. 7:1999;652-658.
11. Hiltunen M., Mannermaa A., Thompson D., Easton D., Pirskanen M., Helisalmi S., Koivisto A.M., Lehtovirta M., Ryynanen M., Soininen H. Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland. Neurology. 57:2001;1663-1668.
12. Isola J., DeVries S., Chu L., Ghazvini S., Waldman F. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am. J. Pathol. 145:1994;1301-1308.
13. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
14. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
15. Noonan D.M., Fulle A., Valente P., Cai S., Horigan E., Sasaki M., Yamada Y., Hassell J.R. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J. Biol. Chem. 266:1991;22939-22947.
16. Paka L., Goldberg I.J., Obunike J.C., Choi S.Y., Saxena U., Goldberg I.D., Pillarisetti S. Perlecan mediates the antiproliferative effect of apolipoprotein E on smooth muscle cells. An underlying mechanism for the modulation of smooth muscle cell growth? J. Biol. Chem. 274:1999;36403-36408.
17. Paka L., Kako Y., Obunike J.C., Pillarisetti S. Apolipoprotein E containing high density lipoprotein stimulates endothelial production of heparan sulfate rich in biologically active heparin-like domains. A potential mechanism for the anti-atherogenic actions of vascular apolipoprotein e. J. Biol. Chem. 274:1999;4816-4823.
18. Snow A.D., Sekiguchi R.T., Nochlin D., Kalaria R.N., Kimata K. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. Am. J. Pathol. 144:1994;337-347.
19. Tsukamoto K., Watanabe T., Matsushima T., Kinoshita M., Kato H., Hashimoto Y., Kurokawa K., Teramoto T. Determination by PCR-RFLP of apo E genotype in a Japanese population. J. Lab. Clin. Med. 121:1993;598-602.
20. Vandenplas S., Wiid I., Grobler-Rabie A., Brebner K., Ricketts M., Wallis G., Bester A., Boyd C., Mathew C. Blot hybridisation analysis of genomic DNA. J. Med. Genet. 21:1984;164-172.
21. van Horssen J., Kleinnijenhuis J., Maass C.N., Rensink A.A., Otte-Holler I., David G., van den Heuvel L.P., Wesseling P., de Waal R.M., Verbeek M.M. Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques. Neurobiol. Aging. 23:2002;537-545.